Inactive Instrument

Calendar bioMérieux Euronext Paris

Equities

FR0010096479

Chart calendar bioMérieux

18b4d8123da8d.TLNcICMEsh78KASDPR4c7jxFAWMRMVJ3fTt_Oxns3JY.G-YIEVRb4FyXW1H1Sngx3WY_dBclQT4HUFQpYmqNutQl0B5UaUzxeo1OYw~7de1172e03afefef2f2fb3f78f70358e

Upcoming events on bioMérieux

2024-05-22 Annual General Meeting
2024-06-06 Ex-dividend day for final dividend
2024-09-03 Q2 2024 Earnings Call
2024-09-04 01:00 am Q2 2024 Earnings Release
2024-10-23 Q3 2024 Sales and Revenue Call
2024-10-24 01:00 am Q3 2024 Sales and Revenue Release
2025-02-25 Q4 2024 Earnings Release (Projected)
2025-09-02 Q2 2025 Earnings Release (Projected)
2026-03-03 Q4 2025 Earnings Release (Projected)
2026-09-08 Q2 2026 Earnings Release (Projected)

Past events on bioMérieux

2024-04-09 03:30 am Capital Markets Day - Q1 2024 Sales and Revenue
2024-04-09 01:00 am Q1 2024 Sales and Revenue Release
2024-03-14 09:30 am Q4 2023 Earnings Call
2024-03-14 02:00 am Q4 2023 Earnings Release
2023-10-26 09:00 am Q3 2023 Sales and Revenue Call
2023-10-26 01:00 am Q3 2023 Sales and Revenue Release
2023-09-01 08:00 am Q2 2023 Earnings Call
2023-09-01 01:00 am Q2 2023 Earnings Release
2023-06-05 Ex-dividend day for final dividend
2023-05-22 Annual General Meeting
2023-04-27 08:00 am Q1 2023 Sales and Revenue Call
2023-04-27 01:00 am Q1 2023 Sales and Revenue Release
2023-03-08 08:00 am Q4 2022 Earnings Call
2023-03-08 01:00 am Q4 2022 Earnings Release
2022-12-04 Berenberg European Conference
2022-10-26 09:00 am Q3 2022 Sales and Revenue Call
2022-10-26 01:00 am Q3 2022 Sales and Revenue Release
2022-08-31 08:30 am Interim 2022 Earnings Call
2022-08-30 Interim 2022 Earnings Release
2022-06-05 Ex-dividend day for final dividend

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
2 675
2 642
1.23%
3 118
3 131
-0.4%
3 376
3 331
1.37%
3 589
3 550
1.1%
3 675
3 675
-0.01%

3 903

EBITDA
Million EUR
Released
Forecast
Spread
578
572
0.95%
824
782
5.34%
1 032
954
8.19%
864
873
-0.99%
827
821
0.73%

882

EBIT
Million EUR
Released
Forecast
Spread
371
387
-4.3%
595
555
7.25%
784
753
4.12%
587
629
-6.59%
439
547
-19.8%

594

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
348
359
-3.12%
524
510
2.71%
774
726
6.58%
581
618
-6.02%
437
533
-18.01%

582

Net income
Million EUR
Released
Forecast
Spread
273
278
-1.77%
404
405
-0.13%
601
560
7.26%
452
483
-6.25%
358
408
-12.21%

466

EPS
EUR
Released
Forecast
Spread
2,30
2,34
-1.51%
3,41
3,41
0.12%
5,06
4,59
10.24%
3,82
3,93
-2.88%
3,01
3,45
-12.72%

3,89

Announcement Date26/02/2024/02/2102/03/2207/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales
Million EUR
Released
Forecast
Spread
1 400
1 397
0.23%
1 476
1 527
-3.34%
1 642
1 611
1.94%
1 574
1 601
-1.67%
924
903
2.37%
821
730
12.45%
1 658
1 567
5.81%
902
855
5.46%
1 029
1 029
0.01%
1 931
1 931
0.01%
864
1 658
-47.87%
1 770
1 774
-0.22%
898
935
-3.95%
1 006
1 022
-1.58%




965


913


1 878


955


1 101


2 056

EBIT
Million EUR
Released
Forecast
Spread
182
192
-5.59%
244
223
9.27%
351
329
6.82%
366
297
23.01%






297
320
-7.16%






290
334
-13.12%

322

208
300
-30.73%






231
313
-26.18%







265








321

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread






305
320
-4.87%
359
296
20.99%















289
330
-12.39%






















262








318

Net income
Million EUR
Released
Forecast
Spread
132
142
-7.09%
173
173
0.23%
232
245
-5.63%
277
230
20.74%






228
240
-5%






224
255
-12.14%






















207








252

EPS
EUR
Released
Forecast
Spread
1,11
1,16
-4.31%



1,95
2,06
-5.34%
2,33
1,93
20.73%















1,89
2,15
-12.09%






















1,74








2,12

Announcement Date26/02/2002/09/2024/02/2101/09/2102/03/2231/08/2231/08/2226/10/2207/03/2307/03/2331/08/2331/08/2314/12/2314/03/2414/03/24------